144525-40-6

Basic information

• Product Name: Oxyresveratrol 3'-O-β-D-glucopyranoside
• Synonyms: Oxyresveratrol 3'-O-β-D-glucopyranoside;Oxyresveratrol 3'-O-beta-D-glucopyranoside;3-[(1E)-2-(2,4-Dihydroxyphenyl)ethenyl]-5-hydroxyphenyl beta-D-glucopyranoside;Oxyresveratrol 3-O-glucoside
• CAS NO: 144525-40-6
• Molecular Formula: C₂₀H₂₂O₉
• Molecular Weight: 406.38328
• Mol File: 144525-40-6.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Oxyresveratrol 3'-O-β-D-glucopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: Oxyresveratrol 3'-O-β-D-glucopyranoside(144525-40-6)
• EPA Substance Registry System: Oxyresveratrol 3'-O-β-D-glucopyranoside(144525-40-6)

Safety Data

• Hazardous Substances Data: 144525-40-6(Hazardous Substances Data)

Usage

General Description

Oxyresveratrol 3'-O-β-D-glucopyranoside is a chemical compound that is a glucoside derivative of oxyresveratrol, a type of stilbenoid. It is found in various plant species and has been studied for its potential biological activities, including antioxidant, anti-inflammatory, and anti-cancer properties. The glucoside form of oxyresveratrol allows for better stability and solubility, making it potentially more beneficial for use in pharmaceutical or cosmetic applications. Its antioxidant activity has been of particular interest for its potential to protect against oxidative damage and inflammation, making it a promising candidate for further research and development in the field of natural compounds with health benefits.

Upstream product

• 102841-42-9 oxyresveratrol-4-O-β-D-glucopyranosyl-3'-O-β-2, 4, 3', 5'-tetrahydroxystilbene 

Relevant articles and documents

Enhancement of the tyrosinase inhibitory activity of Mori Cortex Radicis extract by biotransformation using Leuconostoc paramesenteroides PR

Mori Cortex Radicis (MCR), the root bark of Morus alba L., consists of various phytochemicals and exhibits a strong inhibitory effect on tyrosinase. To enhance the tyrosinase inhibitory activity of MCR extract without further purification of bioactive compounds, whole MCR extract was biotransformed with crude enzyme extract from a selected lactic acid bacterium, Leuconostoc paramesenteroides PR (LP). Mulberroside A (MA), a major stilbene glucoside of MCR, contains two β-glucosyl residues at the C3 and C40 positions of oxyresveratrol (OXY). The crude enzyme of LP hydrolyzed the two glycosidic bonds of MA effectively, and 97.1% of MA was biotransformed into OXY within 2 h. Commercial almond β-glucosidase hydrolyzed only one site of the two glycosidic bonds of MA, and 68.7% of MA was biotransformed to OXY-glucoside. The tyrosinase inhibitory activity of the crude extract of MCR was increased approximately 6.5-fold by biotransformation using LP, and the IC50 value of the transformed MCR was 3.7μg/mL.